Dr Goran Ando joins Xeophin as Chairman of the Clinical Advisory Committee

The team here at Xeophin are very please to announce the appointment of Dr Ando to Xeophin’s Clinical Advisory Committee. Dr Ando's helps solidify Xeophin and it’s technology’s position within the Biotechnology space as a compelling anti-inflammatory business. Dr Ando’s extensive experience in the Pharmaceutical Industry will not only benefit Xeophin in executing a successful clinical strategy, but will also serve to give confidence to the wider capital markets that Xeophin’s value and clinical outcomes are driven by Dr Ando’s legacy of leadership in both the Pharmaceutical Industries and the Venture Capital space.

Read More
Troy Neilson